Skip to main content
Clinical Trials/NCT02064660
NCT02064660CompletedPhase 1

An Integrative Medical Approach of Acupoint Stimulation for Children With Myopia : A Pilot Study

Korean Medicine Hospital of Pusan National University2 sites in 1 country20 target enrollmentStarted: December 1, 2013Last updated:
Conditions

Trial Snapshot

Phase
Phase 1
Status
Completed
Sponsor
Enrollment
20
Locations
2
Primary Endpoint
Refractive error

Study Overview

Brief Summary

Myopia is widely one of the three commonly detected refractive errors. Myopia is usually managed by correction through glasses or contact lenses. Other alternative available include surgery, drugs and acupuncture. There are various therapeutic approaches and different points can be used in acupuncture treatment for myopia, such as auricular acupuncture, acupressure body acupuncture. However, the mechanism of acupuncture therapy for myopia is largely unknown. Furthermore, little information exists regarding the effects and safety of acupuncture for degenerative myopia in children.

The investigators aimed to assess the overall effectiveness, safety of periocular acupressure for children with myopia

The hypotheses of this study are as follows:

Periocular acupressure is effective for myopia progression delay.

The study aims to include 56 participants.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Prevention
Masking
None

Eligibility Criteria

Ages
7 Years to 12 Years (Child)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Aged 7-12 years
  • Spherical equivalent greater than -5D
  • Individuals without strabismus, anistopia
  • Willingness to participate in the study

Exclusion Criteria

  • The presence of a related disease such as cataract, glaucoma, or other eye disease.
  • Individuals who were received ocular or scalp trauma.
  • Individuals who were received ocular surgery and had ocular wound.
  • Individuals who were adapted bifocal lense.
  • Individuals suffering fever or bad conditions.
  • Individuals suffering systemic or neurologic disease.
  • Indibiduals who were receiving other therapy during the period of study
  • Individuals who did not comply with the treatment which affected myopia progression.

Outcomes

Primary Outcomes

Refractive error

Time Frame: 6 months

Change from baseline in the refractive erros will be used.

Secondary Outcomes

  • Axial length(6 months)

Investigators

Sponsor
Korean Medicine Hospital of Pusan National University
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Ki-Bong, Kim

Assistant Professor

Korean Medicine Hospital of Pusan National University

Study Sites (2)

Loading locations...

Similar Trials